FDA Cancels Planned Safety Review of COVID and Shingles Vaccines
2026-05-06
"Withdrawn" is a severe word for a safety paper, yet it now hangs over two government‑backed studies that once reassured the public about Covid and shingles vaccines. The agency confirmed that the papers were removed because, as a spokesperson told CNBC, the authors drew broad conclusions not supported by the underlying data sets.
This reversal signals less a scandal than a harsh audit of scientific rhetoric. Safety surveillance systems such as the Vaccine Adverse Event Reporting System and near‑real‑time sequential monitoring are designed to flag statistical signals, not to grant blanket exoneration, and regulators appear to be reasserting that boundary after the fact. When an analysis built on observational data and post‑marketing pharmacovigilance is written as if it were a randomized controlled trial, the language can drift well beyond what confidence intervals and power calculations allow.
The more unsettling point is that the correction arrives late, after the studies have circulated through media coverage, policy debates and social networks. Retractions and withdrawals rarely travel as far as the original claims, yet the scientific record now contains a conspicuous gap where categorical reassurance used to sit, and into that gap will flow both legitimate scrutiny and opportunistic doubt.
Loading...
